Connection

Jonathan Douxfils to Partial Thromboplastin Time

Back to Details
This is a "connection" page, showing publications Jonathan Douxfils has written about Partial Thromboplastin Time.
Jonathan Douxfils
Connection Strength
0.473
Partial Thromboplastin Time
  1. Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents. Int J Lab Hematol. 2019 Jun; 41(3):316-324.
    View in: PubMed
    Score: 0.166
  2. Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory Guide. Thromb Haemost. 2018 Jul; 118(7):1203-1214.
    View in: PubMed
    Score: 0.158
  3. International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants. Thromb Haemost. 2018 03; 118(3):437-450.
    View in: PubMed
    Score: 0.039
  4. Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures. Expert Opin Biol Ther. 2017 10; 17(10):1275-1296.
    View in: PubMed
    Score: 0.037
  5. Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme. Int J Lab Hematol. 2017 Aug; 39(4):402-408.
    View in: PubMed
    Score: 0.036
  6. Inactivation of human coagulation factor X by a protease of the pathogen Capnocytophaga canimorsus. J Thromb Haemost. 2017 03; 15(3):487-499.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.